Advertisement
AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?
7 min.
LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?
6 min.
US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation
14 min.
Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device
11 min.
Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials
8 min.
First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study
11 min.
Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?
12 min.
One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial
19 min.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results
20 min.
Left Atrial Appendage Closure with a Mapping Decapolar Catheter Utilizing a Jugular Vein Approach After Failed Femoral Vein Attempt
11 min.
Innovative Use of PDA Amplatzer Devices for Occlusion of Small-Bore LA-LAA Communications Following Incomplete Surgical LAA Ligation
11 min.
Case 2: Discordance Imaging: Sizing and Device Selection With Standard Imaging Resources (TEE or CTA)
13 min.
Case 3: My Clinical and Anatomical Inclusion/Exclusion Criteria for Selecting Patients for ICE-Guided LAAO
16 min.